You have 9 free searches left this month | for more free features.

recurrent childhood visual pathway and hypothalamic glioma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

Recruiting
  • Refractory Cancer
  • +14 more
  • Atlanta, Georgia
  • +1 more
Oct 23, 2023

Juvenile Pilocytic Astrocytomas, Optic Pathway Gliomas Trial in Atlanta (Pegylated interferon alpha-2b)

Completed
  • Juvenile Pilocytic Astrocytomas
  • Optic Pathway Gliomas
  • Pegylated interferon alpha-2b
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Jan 18, 2022

Neurofibromatosis Type 1, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Visual Pathway Glioma Trial in United

Completed
  • Neurofibromatosis Type 1
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Los Angeles, California
  • +11 more
Apr 22, 2022

Neurofibromatosis Type 1, Recurrent Childhood Pilocytic Astrocytoma, Recurrent Childhood Visual Pathway Glioma Trial in

Active, not recruiting
  • Neurofibromatosis Type 1
  • +2 more
  • Birmingham, Alabama
  • +125 more
Jan 25, 2023

Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • +9 more
  • DNA analysis
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 28, 2021

Optic Pathway Glioma Trial in Rome (CHF6467, Placebo)

Not yet recruiting
  • Optic Pathway Glioma
  • Rome, Italy
    Catholic University, Policlinico A. Gemelli (Hospital)
Feb 17, 2023

Recurrent Low Grade Astrocytoma, Recurrent WHO Grade 2 Glioma, Refractory Low Grade Astrocytoma Trial in Canada, United States

Recruiting
  • Recurrent Low Grade Astrocytoma
  • +4 more
  • Quality-of-Life Assessment
  • +3 more
  • Birmingham, Alabama
  • +64 more
Aug 20, 2022

Pilomyxoid Astrocytoma, Pilocytic Astrocytoma, Glioma, Astrocytic Trial in New Hyde Park (Mebendazole, Vincristine, Carboplatin)

Recruiting
  • Pilomyxoid Astrocytoma
  • +11 more
  • New Hyde Park, New York
    Cohen Children's Medical Center of New York
Mar 3, 2021

Optic Glioma, Pediatric Brain Tumor, Optic Nerve Glioma Trial in Beijing (Carboplatin, Vincristine, Recombinant human

Recruiting
  • Optic Glioma
  • Pediatric Brain Tumor, Optic Nerve Glioma
  • Beijing, China
    Capital Medical University Sanbo Brain Hospital
Jul 4, 2022

Neurofibromatosis Type 1, Plexiform Neurofibroma, Optic Nerve Glioma Trial in London (Selumetinib)

Recruiting
  • Neurofibromatosis Type 1
  • +2 more
  • London, United Kingdom
  • +1 more
Nov 11, 2021

High Grade Glioma, Glioma, Glioma, Malignant Trial in Phoenix (Temsirolimus)

Not yet recruiting
  • High Grade Glioma
  • +3 more
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
Mar 6, 2023

Iris Color and Day-Night Changes in the Sympathovagal Ratio

Completed
  • Iris Diseases
  • Iris Color Measurement , LF/HF Measurement
  • (no location specified)
Mar 7, 2023

Brain Tumors Trial in San Diego, Atlanta (Poly ICLC)

Completed
  • Brain Tumors
  • Poly ICLC
  • San Diego, California
  • +1 more
Apr 20, 2022

Pontine Glioma Trial in Phoenix, Grand Rapids (Vismodegib)

Terminated
  • Pontine Glioma
  • Phoenix, Arizona
  • +1 more
Apr 20, 2022

High Grade Glioma, Glioblastoma Multiforme Trial in Japan, United States (DSP-0390)

Recruiting
  • High Grade Glioma
  • Glioblastoma Multiforme
  • San Francisco, California
  • +8 more
Dec 16, 2022

Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)

Terminated
  • Glioma
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Sep 26, 2022

Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,

Not yet recruiting
  • Recurrent Glioblastoma, IDH-Wildtype
  • +2 more
  • Biospecimen Collection
  • +2 more
  • (no location specified)
May 13, 2023

Glioma Trial in Spain, United States (LY2157299, Lomustine)

Active, not recruiting
  • Glioma
  • Baltimore, Maryland
  • +3 more
Oct 18, 2022

Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +37 more
  • Birmingham, Alabama
  • +171 more
Aug 24, 2022

CNS Tumors, Medulloblastoma Trial in Worldwide (Pomalidomide)

Active, not recruiting
  • Central Nervous System Neoplasms
  • Medulloblastoma
  • Stanford, California
  • +24 more
Sep 28, 2022

Malignant Glioma, Glioblastoma Trial in Durham (Evolocumab)

Recruiting
  • Malignant Glioma
  • Glioblastoma
  • Durham, North Carolina
    Duke University Medical Center
Oct 13, 2022

Glioblastoma, Astrocytoma, Oligodendroglioma Trial (OKN-007)

Withdrawn
  • Glioblastoma
  • +2 more
  • (no location specified)
Oct 5, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

Recruiting
  • Glioblastoma Multiforme
  • +5 more
  • Los Angeles, California
  • +12 more
Jan 9, 2023